We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 1,808 results
  1. Nationwide incidence of myotonic dystrophy type 1 and the status of multi-organ involvement

    Purpose

    This study aimed to investigate the incidence of myotonic dystrophy type 1 (DM1) and the status of multi-organ involvement.

    Methods ...
    Ju-Yeun Lee, Ha-Neul Jeong in Journal of Neurology
    Article 26 October 2021
  2. Development of prediction models based on respiratory assessments to determine the need for non-invasive ventilation in patients with myotonic dystrophy type 1

    Introduction

    Myotonic dystrophy type 1 is a slowly progressive, multisystem, autosomal dominant disorder, in which the impairments of respiratory...

    Andrea Lizio, Alice Pirola, ... Valeria Ada Sansone in Neurological Sciences
    Article 25 January 2023
  3. Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death

    Objectives

    The mechanism and pathological substrate of arrhythmogenic events in dystrophic myopathy type 1 (DM1) have not been fully established,...

    Yukiko Hata, Shojiro Ichimata, ... Naoki Nishida in Journal of Neurology
    Article 11 July 2023
  4. Remimazolam for a patient with myotonic dystrophy type 1 who underwent endoscopic retrograde cholangiopancreatography under general anesthesia: a case report

    Background

    Remimazolam is a benzodiazepine receptor agonist with an ultra-short-acting anesthetic effect. We used remimazolam for anesthesia in a...

    Masakazu Fukuda, Shunsuke Tachibana, ... Michiaki Yamakage in JA Clinical Reports
    Article Open access 24 February 2021
  5. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1)

    Background

    Cognitive and behavioural symptoms due to involvement of the central nervous system (CNS) are among the main clinical manifestations of...

    Tommaso F. Nicoletti, Salvatore Rossi, ... Gabriella Silvestri in Journal of Neurology
    Article Open access 16 May 2022
  6. Anesthetic management for a patient with myotonic dystrophy with remimazolam

    Background

    Patients with myotonic dystrophy may have increased sensitivity to drugs used for anesthesia. We successfully managed general anesthesia in...

    Yasuhiro Morimoto, Aya Yoshimatsu, Manabu Yoshimura in JA Clinical Reports
    Article Open access 12 January 2021
  7. Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019

    Background

    Myotonic dystrophy (DM) is a rare, inherited disorder with multi-systemic effects that impact the skeletal muscles, eyes, heart, skin and...

    Sarah J. Howe, David Lapidus, ... Jacinda B. Sampson in Orphanet Journal of Rare Diseases
    Article Open access 23 February 2022
  8. Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report

    Background

    Myotonic dystrophy (dystrophia myotonica [DM]) is an autosomal-dominant inheritance, and myasthenia gravis (MG) is an autoimmune disease...

    Michiyo Miyawaki, Mika Jikumaru, ... Kenji Sugio in Surgical Case Reports
    Article Open access 08 July 2021
  9. A patient with myotonic dystrophy diagnosed after experiencing sudden respiratory failure: a case report

    Background

    Myotonic dystrophy is a disorder affecting multiple organs including skeletal muscles and causes respiratory failure. We describe a patient...

    Noriaki Nishihara, Shunsuke Tachibana, ... Michiaki Yamakage in JA Clinical Reports
    Article Open access 08 October 2020
  10. Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1

    Objective

    To investigate Tau pathology using multimodal biomarkers of neurodegeneration and neurocognition in participants with myotonic dystrophy...

    Robert Jr Laforce, Caroline Dallaire-Théroux, ... Jack Puymirat in Journal of Neurology
    Article Open access 01 February 2022
  11. Spontaneous Diaphragmatic Rupture in Muscular Dystrophy Misdiagnosed as Pneumothorax: a Case Report

    Diaphragmatic rupture is almost always iatrogenic with variable presentation. It should be diagnosed with high suspicion index in blunt thoracic...

    Pavan Kumar Dammalapati in SN Comprehensive Clinical Medicine
    Article 30 November 2023
  12. Pain in adult myotonic dystrophy type 1: relation to function and gender

    Background

    Pain is prevalent in myotonic dystrophy 1 (DM1). This study investigated whether CTG repeat size, disease duration, BMI and motor and...

    Gro Solbakken, Sissel Løseth, ... Kristin Ørstavik in BMC Neurology
    Article Open access 04 March 2021
  13. Fuchs endothelial corneal dystrophy: an updated review

    Purpose

    The present review will summarize FECD-associated genes and pathophysiology, diagnosis, current  therapeutic approaches, and future treatment...

    Francisco Altamirano, Gustavo Ortiz-Morales, ... Jorge E. Valdez-Garcia in International Ophthalmology
    Article 12 February 2024
  14. A retrospective study of accuracy and usefulness of electrophysiological exercise tests

    Objectives

    This study aimed to determine the usefulness of electrophysiological exercise tests. The significance of slightly abnormal exercise tests...

    Vesa Periviita, Manu Jokela, ... Bjarne Udd in Journal of Neurology
    Article Open access 06 December 2023
  15. Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United States

    Background

    Direct estimates of rare disease prevalence from public health surveillance may only be available in a few catchment areas. Understanding...

    Nedra Whitehead, Stephen W. Erickson, ... Li**g Ouyang in Orphanet Journal of Rare Diseases
    Article Open access 22 March 2023
  16. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study

    Introduction

    Myotonic dystrophy type 1 (DM1) is a progressive, multisystemic, and autosomal dominant disease. Muscle wasting and weakness have been...

    Marie-Pier Roussel, Marie-Michèle Fiset, ... Elise Duchesne in Journal of Neurology
    Article 27 April 2021
  17. Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances

    Purpose

    Myotonic dystrophy type 1 (DM1) is a muscular dystrophy with neurological, cognitive, and radiological abnormalities. The developmental or...

    T. Cabada, J. Díaz, ... M. Gomez in Neuroradiology
    Article 25 November 2020
  18. Event-related potentials using the auditory novel paradigm in patients with myotonic dystrophy

    Many neuropsychological disorders, especially attentional abnormality, are present in patients with myotonic dystrophy type 1 (DM1), but the...

    Shugo Suwazono, Hiroshi Arao, ... Shino Maedou in Journal of Neurology
    Article 20 February 2021
Did you find what you were looking for? Share feedback.